| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inhibitory MHC class I receptor activity | 1.84e-04 | 12 | 34 | 2 | GO:0032396 | |
| GeneOntologyMolecularFunction | calcium ion binding | 2.25e-04 | 749 | 34 | 7 | GO:0005509 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 3.33e-04 | 16 | 34 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | MHC class I receptor activity | 4.23e-04 | 18 | 34 | 2 | GO:0032393 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 4.31e-04 | 210 | 34 | 4 | GO:0019903 | |
| GeneOntologyMolecularFunction | peptidoglycan binding | 4.73e-04 | 19 | 34 | 2 | GO:0042834 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 5.25e-04 | 20 | 34 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | oligosaccharide binding | 5.25e-04 | 20 | 34 | 2 | GO:0070492 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 5.79e-04 | 21 | 34 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 8.91e-04 | 26 | 34 | 2 | GO:0050431 | |
| GeneOntologyMolecularFunction | phosphatase binding | 1.01e-03 | 264 | 34 | 4 | GO:0019902 | |
| GeneOntologyMolecularFunction | growth factor binding | 2.34e-03 | 156 | 34 | 3 | GO:0019838 | |
| GeneOntologyMolecularFunction | growth factor activity | 3.14e-03 | 173 | 34 | 3 | GO:0008083 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 3.23e-03 | 599 | 34 | 5 | GO:0050839 | |
| GeneOntologyMolecularFunction | integrin binding | 3.24e-03 | 175 | 34 | 3 | GO:0005178 | |
| GeneOntologyBiologicalProcess | pancreas regeneration | 2.48e-06 | 2 | 33 | 2 | GO:1990798 | |
| GeneOntologyBiologicalProcess | positive regulation of acinar cell proliferation | 7.44e-06 | 3 | 33 | 2 | GO:1904699 | |
| GeneOntologyBiologicalProcess | acinar cell proliferation | 2.47e-05 | 5 | 33 | 2 | GO:1990863 | |
| GeneOntologyBiologicalProcess | regulation of acinar cell proliferation | 2.47e-05 | 5 | 33 | 2 | GO:1904697 | |
| GeneOntologyBiologicalProcess | pulmonary artery morphogenesis | 3.71e-05 | 6 | 33 | 2 | GO:0061156 | |
| GeneOntologyBiologicalProcess | positive regulation of type B pancreatic cell proliferation | 6.91e-05 | 8 | 33 | 2 | GO:1904692 | |
| GeneOntologyCellularComponent | dendrite | 1.04e-04 | 858 | 37 | 8 | GO:0030425 | |
| GeneOntologyCellularComponent | cell surface | 1.06e-04 | 1111 | 37 | 9 | GO:0009986 | |
| GeneOntologyCellularComponent | dendritic tree | 1.06e-04 | 860 | 37 | 8 | GO:0097447 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 2.25e-04 | 1228 | 37 | 9 | GO:0036477 | |
| GeneOntologyCellularComponent | growth cone | 8.97e-04 | 245 | 37 | 4 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 1.01e-03 | 253 | 37 | 4 | GO:0030427 | |
| GeneOntologyCellularComponent | zymogen granule | 1.46e-03 | 32 | 37 | 2 | GO:0042588 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 2.09e-03 | 519 | 37 | 5 | GO:0009897 | |
| GeneOntologyCellularComponent | neuronal cell body membrane | 2.63e-03 | 43 | 37 | 2 | GO:0032809 | |
| GeneOntologyCellularComponent | cell body membrane | 3.13e-03 | 47 | 37 | 2 | GO:0044298 | |
| GeneOntologyCellularComponent | side of membrane | 4.05e-03 | 875 | 37 | 6 | GO:0098552 | |
| GeneOntologyCellularComponent | dendrite membrane | 4.42e-03 | 56 | 37 | 2 | GO:0032590 | |
| GeneOntologyCellularComponent | axon | 4.42e-03 | 891 | 37 | 6 | GO:0030424 | |
| GeneOntologyCellularComponent | cell body | 5.41e-03 | 929 | 37 | 6 | GO:0044297 | |
| MousePheno | delayed liver regeneration | 5.77e-05 | 6 | 28 | 2 | MP:0031324 | |
| MousePheno | iris coloboma | 1.38e-04 | 9 | 28 | 2 | MP:0010714 | |
| MousePheno | short snout | 1.46e-04 | 136 | 28 | 4 | MP:0000445 | |
| MousePheno | small snout | 1.82e-04 | 144 | 28 | 4 | MP:0030190 | |
| MousePheno | uveal coloboma | 2.10e-04 | 11 | 28 | 2 | MP:0012533 | |
| Domain | EGF_CA | 9.68e-09 | 86 | 34 | 6 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 2.01e-08 | 97 | 34 | 6 | IPR018097 | |
| Domain | EGF_CA | 2.27e-08 | 99 | 34 | 6 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.41e-08 | 100 | 34 | 6 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.42e-08 | 106 | 34 | 6 | IPR000152 | |
| Domain | EGF_CA | 7.95e-08 | 122 | 34 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 8.76e-08 | 124 | 34 | 6 | IPR001881 | |
| Domain | Growth_fac_rcpt_ | 3.42e-07 | 156 | 34 | 6 | IPR009030 | |
| Domain | EGF_3 | 3.73e-06 | 235 | 34 | 6 | PS50026 | |
| Domain | EGF | 3.73e-06 | 235 | 34 | 6 | SM00181 | |
| Domain | EGF-like_dom | 5.20e-06 | 249 | 34 | 6 | IPR000742 | |
| Domain | EGF_1 | 5.96e-06 | 255 | 34 | 6 | PS00022 | |
| Domain | EGF-like_CS | 6.81e-06 | 261 | 34 | 6 | IPR013032 | |
| Domain | EGF_2 | 7.43e-06 | 265 | 34 | 6 | PS01186 | |
| Domain | cEGF | 1.39e-05 | 26 | 34 | 3 | IPR026823 | |
| Domain | cEGF | 1.39e-05 | 26 | 34 | 3 | PF12662 | |
| Domain | TB | 6.72e-05 | 7 | 34 | 2 | PF00683 | |
| Domain | EGF | 7.83e-05 | 126 | 34 | 4 | PF00008 | |
| Domain | - | 8.95e-05 | 8 | 34 | 2 | 3.90.290.10 | |
| Domain | TB | 1.15e-04 | 9 | 34 | 2 | PS51364 | |
| Domain | TB_dom | 1.15e-04 | 9 | 34 | 2 | IPR017878 | |
| Domain | Ldl_recept_b | 2.89e-04 | 14 | 34 | 2 | PF00058 | |
| Domain | LDLRB | 2.89e-04 | 14 | 34 | 2 | PS51120 | |
| Domain | LY | 3.33e-04 | 15 | 34 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 3.33e-04 | 15 | 34 | 2 | IPR000033 | |
| Domain | hEGF | 1.18e-03 | 28 | 34 | 2 | PF12661 | |
| Domain | - | 2.29e-03 | 39 | 34 | 2 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 2.40e-03 | 40 | 34 | 2 | IPR023415 | |
| Domain | C-type_lectin_CS | 2.77e-03 | 43 | 34 | 2 | IPR018378 | |
| Domain | Ldl_recept_a | 3.03e-03 | 45 | 34 | 2 | PF00057 | |
| Domain | - | 3.17e-03 | 46 | 34 | 2 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 3.17e-03 | 46 | 34 | 2 | IPR011042 | |
| Domain | LDLRA_1 | 3.44e-03 | 48 | 34 | 2 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 3.59e-03 | 49 | 34 | 2 | IPR002172 | |
| Domain | LDLa | 3.59e-03 | 49 | 34 | 2 | SM00192 | |
| Domain | LDLRA_2 | 3.59e-03 | 49 | 34 | 2 | PS50068 | |
| Domain | ig | 4.92e-03 | 190 | 34 | 3 | PF00047 | |
| Domain | Immunoglobulin | 4.92e-03 | 190 | 34 | 3 | IPR013151 | |
| Domain | EGF_extracell | 5.33e-03 | 60 | 34 | 2 | IPR013111 | |
| Domain | EGF_2 | 5.33e-03 | 60 | 34 | 2 | PF07974 | |
| Domain | - | 6.58e-03 | 663 | 34 | 5 | 2.60.40.10 | |
| Domain | IG | 6.92e-03 | 421 | 34 | 4 | SM00409 | |
| Domain | Ig_sub | 6.92e-03 | 421 | 34 | 4 | IPR003599 | |
| Domain | Ig_2 | 7.80e-03 | 73 | 34 | 2 | PF13895 | |
| Domain | Ig-like_fold | 8.53e-03 | 706 | 34 | 5 | IPR013783 | |
| Domain | IGc2 | 8.83e-03 | 235 | 34 | 3 | SM00408 | |
| Domain | Ig_sub2 | 8.83e-03 | 235 | 34 | 3 | IPR003598 | |
| Domain | C_TYPE_LECTIN_1 | 9.30e-03 | 80 | 34 | 2 | PS00615 | |
| Domain | Lectin_C | 1.02e-02 | 84 | 34 | 2 | PF00059 | |
| Domain | CLECT | 1.02e-02 | 84 | 34 | 2 | SM00034 | |
| Domain | C_TYPE_LECTIN_2 | 1.04e-02 | 85 | 34 | 2 | PS50041 | |
| Domain | C-type_lectin-like | 1.07e-02 | 86 | 34 | 2 | IPR001304 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 9.82e-05 | 8 | 27 | 2 | M47850 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 27539087 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 17463184 | ||
| Pubmed | The expression of REG 1A and REG 1B is increased during acute amebic colitis. | 1.04e-06 | 2 | 36 | 2 | 21586335 | |
| Pubmed | Regenerating 1 and 3b gene expression in the pancreas of type 2 diabetic Goto-Kakizaki (GK) rats. | 1.04e-06 | 2 | 36 | 2 | 24587207 | |
| Pubmed | Mechanism of calcite crystal growth inhibition by the N-terminal undecapeptide of lithostathine. | 1.04e-06 | 2 | 36 | 2 | 10625646 | |
| Pubmed | Partial amino acid sequence of human pancreatic stone protein, a novel pancreatic secretory protein. | 1.04e-06 | 2 | 36 | 2 | 3541906 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 28009527 | ||
| Pubmed | Exacerbation of indomethacin-induced small intestinal injuries in Reg I-knockout mice. | 1.04e-06 | 2 | 36 | 2 | 20508157 | |
| Pubmed | Differential expression of reg-I and reg-II genes during aging in the normal mouse. | 1.04e-06 | 2 | 36 | 2 | 8808978 | |
| Pubmed | Preferential expression of reg I beta gene in human adult pancreas. | 1.04e-06 | 2 | 36 | 2 | 11396963 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 23986224 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 8961348 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 17898082 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 2332435 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 10526060 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 29935186 | ||
| Pubmed | Expression of Reg family genes in the gastrointestinal tract of mice treated with indomethacin. | 1.04e-06 | 2 | 36 | 2 | 25747353 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 3665916 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 2394826 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 25767811 | ||
| Pubmed | RegII is a beta-cell protein and autoantigen in diabetes of NOD mice. | 1.04e-06 | 2 | 36 | 2 | 17192462 | |
| Pubmed | Isolation, structural determination and expression of a novel reg gene, human regI beta. | 1.04e-06 | 2 | 36 | 2 | 8110835 | |
| Pubmed | Crystal structure of human lithostathine, the pancreatic inhibitor of stone formation. | 1.04e-06 | 2 | 36 | 2 | 8654365 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 20157293 | ||
| Pubmed | No abnormalities of reg1 alpha and reg1 beta gene associated with diabetes mellitus. | 1.04e-06 | 2 | 36 | 2 | 11796176 | |
| Pubmed | Isolation, characterization, and distribution of an unusual pancreatic human secretory protein. | 1.04e-06 | 2 | 36 | 2 | 3908481 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 2525567 | ||
| Pubmed | Cleavage of the Arg-Ile bond in the native polypeptide chain of human pancreatic stone protein. | 1.04e-06 | 2 | 36 | 2 | 3108036 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 2764894 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 12369899 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 17133485 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 20919961 | ||
| Pubmed | A gene homologous to the reg gene is expressed in the human pancreas. | 1.04e-06 | 2 | 36 | 2 | 8348956 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 20489047 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 18712671 | ||
| Pubmed | Diabetes and tumor formation in transgenic mice expressing Reg I. | 1.04e-06 | 2 | 36 | 2 | 11097844 | |
| Pubmed | mReg2 inhibits nuclear entry of apoptosis-inducing factor in mouse insulinoma cells. | 1.04e-06 | 2 | 36 | 2 | 25370781 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 8522062 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 2963000 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 8340418 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 2493268 | ||
| Pubmed | Isolation and characterization of human reg protein produced in Saccharomyces cerevisiae. | 1.04e-06 | 2 | 36 | 2 | 2226837 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 12475793 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 36470473 | ||
| Pubmed | Regenerating gene I regulates interleukin-6 production in squamous esophageal cancer cells. | 3.12e-06 | 3 | 36 | 2 | 20056108 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 36063729 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 22158612 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 30914711 | ||
| Pubmed | Human regeneration protein/lithostathine genes map to chromosome 2p12. | 3.12e-06 | 3 | 36 | 2 | 8333731 | |
| Pubmed | Megalin mediates selenoprotein P uptake by kidney proximal tubule epithelial cells. | 3.12e-06 | 3 | 36 | 2 | 18174160 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 24801175 | ||
| Pubmed | Cyclin D1 activation through ATF-2 in Reg-induced pancreatic beta-cell regeneration. | 3.12e-06 | 3 | 36 | 2 | 16405968 | |
| Pubmed | Isolation of a novel latent transforming growth factor-beta binding protein gene (LTBP-3). | 3.12e-06 | 3 | 36 | 2 | 7730318 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 18672106 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 19969026 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 10743502 | ||
| Pubmed | Role of regenerating gene I in claudin expression and barrier function in the small intestine. | 6.24e-06 | 4 | 36 | 2 | 27055226 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 20050810 | ||
| Pubmed | REG gene expression in inflamed and healthy colon mucosa explored by in situ hybridisation. | 6.24e-06 | 4 | 36 | 2 | 23519454 | |
| Pubmed | Regenerating (reg) and insulin genes are expressed in prepancreatic mouse embryos. | 6.24e-06 | 4 | 36 | 2 | 8863190 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 23651543 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 15611103 | ||
| Pubmed | Reg3β deficiency impairs pancreatic tumor growth by skewing macrophage polarization. | 6.24e-06 | 4 | 36 | 2 | 23867474 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 23147030 | ||
| Pubmed | Intestinally secreted C-type lectin Reg3b attenuates salmonellosis but not listeriosis in mice. | 6.24e-06 | 4 | 36 | 2 | 22252863 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 31166710 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 24760755 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 9008713 | ||
| Pubmed | The latent transforming growth factor beta binding protein (LTBP) family. | 6.24e-06 | 4 | 36 | 2 | 11104663 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 29339122 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 20876350 | ||
| Pubmed | Coordinated age-dependent and pancreatic-specific expression of mouse Reg2Reg3α, and Reg3β genes. | 6.24e-06 | 4 | 36 | 2 | 21410322 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 28415799 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 16157329 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 10767532 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 16909126 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 18678917 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 16101684 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 19897194 | ||
| Pubmed | Epithelial IL-23R Signaling Licenses Protective IL-22 Responses in Intestinal Inflammation. | 1.04e-05 | 5 | 36 | 2 | 27524624 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 9055810 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 29850784 | ||
| Pubmed | Mapping of 20 polymorphic DNA markers in the rat by somatic hybrid and linkage analysis. | 1.56e-05 | 6 | 36 | 2 | 8903735 | |
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 23811004 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 23269672 | ||
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 10930463 | ||
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 17998301 | ||
| Pubmed | 2.18e-05 | 7 | 36 | 2 | 12169628 | ||
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 9548455 | ||
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 27339457 | ||
| Pubmed | Identification of lectin receptors for conserved SARS-CoV-2 glycosylation sites. | 2.91e-05 | 8 | 36 | 2 | 34375000 | |
| Pubmed | 3.73e-05 | 9 | 36 | 2 | 37395395 | ||
| Pubmed | 3.73e-05 | 9 | 36 | 2 | 22037600 | ||
| Pubmed | Hnf4a deletion in the mouse kidney phenocopies Fanconi renotubular syndrome. | 4.66e-05 | 10 | 36 | 2 | 30046000 | |
| Pubmed | Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development. | 4.66e-05 | 10 | 36 | 2 | 18802077 | |
| Pubmed | A forward genetic screen in mice identifies mutants with abnormal cortical patterning. | 5.70e-05 | 11 | 36 | 2 | 23968836 | |
| Pubmed | Lgr5(+ve) stem/progenitor cells contribute to nephron formation during kidney development. | 5.70e-05 | 11 | 36 | 2 | 22999937 | |
| Pubmed | Gene expression profiling of a mouse model of pancreatic islet dysmorphogenesis. | 6.83e-05 | 12 | 36 | 2 | 18297134 | |
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 9.41e-05 | 14 | 36 | 2 | 17389516 | |
| Pubmed | 1.08e-04 | 15 | 36 | 2 | 17804598 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p12 | 9.14e-04 | 55 | 37 | 2 | chr2p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q15 | 9.47e-04 | 56 | 37 | 2 | chr12q15 | |
| Cytoband | 21q22.11 | 1.16e-03 | 62 | 37 | 2 | 21q22.11 | |
| Cytoband | 19q13.4 | 1.87e-03 | 79 | 37 | 2 | 19q13.4 | |
| Cytoband | 2p12 | 4.05e-03 | 117 | 37 | 2 | 2p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q32 | 4.25e-03 | 120 | 37 | 2 | chr4q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p32 | 6.98e-03 | 155 | 37 | 2 | chr1p32 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 1.49e-05 | 4 | 29 | 2 | 628 | |
| GeneFamily | CD molecules|Inhibitory leukocyte immunoglobulin like receptors | 2.48e-05 | 5 | 29 | 2 | 1182 | |
| GeneFamily | Low density lipoprotein receptors | 1.92e-04 | 13 | 29 | 2 | 634 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.96e-03 | 41 | 29 | 2 | 1298 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 3.43e-03 | 394 | 29 | 4 | 471 | |
| GeneFamily | Keratin associated proteins | 1.31e-02 | 109 | 29 | 2 | 619 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_100 | 1.00e-04 | 60 | 32 | 3 | gudmap_developingKidney_e15.5_Peripheral blastema_100_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_top-relative-expression-ranked_1000 | 1.69e-04 | 811 | 32 | 7 | gudmap_developingKidney_e15.5_S-shaped body_1000 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_500 | 1.76e-04 | 188 | 32 | 4 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k3 | |
| CoexpressionAtlas | alpha beta T cells, T.4.PLN.BDC, 4+ 8- BDC+, Lymph Node, avg-3 | 1.95e-04 | 75 | 32 | 3 | GSM605758_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4.LN.BDC, 4+ 8- BDC+, Lymph Node, avg-3 | 1.95e-04 | 75 | 32 | 3 | GSM605753_100 | |
| CoexpressionAtlas | alpha beta T cells, T.4.Pa.BDC, 4+ 8- BDC+, Pancreas, avg-2 | 2.19e-04 | 78 | 32 | 3 | GSM605756_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.33e-04 | 377 | 32 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k2 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#2_top-relative-expression-ranked_200 | 2.54e-04 | 82 | 32 | 3 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_200_k2 | |
| CoexpressionAtlas | CD positive, CD4 Control, 4+ 8- B220-, Spleen, avg-4 | 2.69e-04 | 210 | 32 | 4 | GSM403995_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_100 | 3.02e-04 | 87 | 32 | 3 | gudmap_developingKidney_e15.5_Peripheral blastema_100 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_top-relative-expression-ranked_500 | 3.10e-04 | 401 | 32 | 5 | gudmap_developingKidney_e11.5_ureteric bud_500 | |
| CoexpressionAtlas | CD positive, CD4 Control, 4+8-B220-, Spleen, avg-2 | 3.44e-04 | 224 | 32 | 4 | GSM403994_500 | |
| ToppCell | 10x_5'_v1-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.18e-05 | 170 | 37 | 4 | dfef8f79960979335b86b4730f224239b40735d5 | |
| ToppCell | 10x_5'_v1-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.18e-05 | 170 | 37 | 4 | fb6098137d010175978596bc382e9ecba9c3891e | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.32e-05 | 175 | 37 | 4 | 2e54961846c65b185d9bd6e305dd81205579d890 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.32e-05 | 175 | 37 | 4 | efa6a05f7417d46141b6e635f258c126b7a03aa1 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.57e-05 | 183 | 37 | 4 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.68e-05 | 186 | 37 | 4 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | Endothelial-Endothelial-E|Endothelial / shred on cell class and cell subclass (v4) | 1.75e-05 | 188 | 37 | 4 | 2777eb7689b271c199021fe7d9db88ccebff14de | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.86e-05 | 191 | 37 | 4 | 05731ece7867659c662f952812805f947032fe10 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.90e-05 | 192 | 37 | 4 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.94e-05 | 193 | 37 | 4 | b25cdca3a1e381784ae48ca73c51cbb6ac62b811 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.94e-05 | 193 | 37 | 4 | b38aaffbea36ef6c08ebe82675438f873c89b242 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.94e-05 | 193 | 37 | 4 | af6ec2c2ba92aef3e41531c3c7215b3300437bd9 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-airway_progenitor_early|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.94e-05 | 193 | 37 | 4 | de569c6e507856fd3ac2311f246cb597074ed30c | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.98e-05 | 194 | 37 | 4 | b19e16a76d7342ff9a665d19c9151652916f17d4 | |
| ToppCell | PCW_05-06-Epithelial|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.98e-05 | 194 | 37 | 4 | 47a1369c22fcbfe00b08376eb610a61c355548db | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.98e-05 | 194 | 37 | 4 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.19e-05 | 199 | 37 | 4 | 85bb28369e0568b7b3bda095722102fc793f60ef | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CHIT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.19e-05 | 199 | 37 | 4 | 54a54ad983503ed515d476882d86b17d97892037 | |
| ToppCell | Severe-Myeloid-Macrophages-FCN1-SPP1+|Severe / Condition, Lineage, Cell class and cell subclass | 2.23e-05 | 200 | 37 | 4 | b8cd209b810312793465b28bb2a6cbe5d94da91f | |
| ToppCell | Monocytes-C1QA+_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.50e-05 | 83 | 37 | 3 | 336137d527d57ebd24670df3d19c62ed889b99e3 | |
| ToppCell | PBMC-Mild-cDC_7|Mild / Compartment, Disease Groups and Clusters | 2.21e-04 | 142 | 37 | 3 | 58f66f35646f281e64d634e6c26adbd1d4e6c830 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.40e-04 | 146 | 37 | 3 | bee5074c29b132180d35f57d307e342efa9b8cd1 | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-04 | 153 | 37 | 3 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-04 | 159 | 37 | 3 | 323cb4a2416d2e6bff0a3f225d2edeae9ab7dc76 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-04 | 163 | 37 | 3 | 4af92b211d12c5b88b65bb746242cd702b545bd0 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L5_RORB_SNHG7|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.31e-04 | 163 | 37 | 3 | 6ed2a71385e85508ed513282c06440add7cc010c | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-04 | 163 | 37 | 3 | d24774e0aa612322c22fdb3b314aef275fa01d68 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-04 | 165 | 37 | 3 | a74751e0ec857aa974bec04ccc747c004a8f6e01 | |
| ToppCell | NS-critical-d_07-13-Myeloid-pDC|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.43e-04 | 165 | 37 | 3 | 17d5c4a111d9b5400780bc5e7b93ce2f5d69ceb7 | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.56e-04 | 167 | 37 | 3 | 1e2fc1637769405a61f4c7e44945712a1888a299 | |
| ToppCell | NS-moderate-d_07-13-Myeloid-pDC|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.62e-04 | 168 | 37 | 3 | d03e91f0e0518b33555c0ec98124fc5ed0f11be5 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac-Macrophage|GI_small-bowel / Manually curated celltypes from each tissue | 3.62e-04 | 168 | 37 | 3 | d5b746d6083c2c8155a0ea345ea368bf6617d5ca | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L3-5_THEMIS_UBE2F|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.62e-04 | 168 | 37 | 3 | bfa1491e8d433933003778b274710d3a16d973cb | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic-pDC|lymph-node_spleen / Manually curated celltypes from each tissue | 3.62e-04 | 168 | 37 | 3 | cfed36fece51871a5abbcde71f6bd5e7212357ff | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.68e-04 | 169 | 37 | 3 | c7fc3a8c44f07c557b60d469717b66e2f5863d38 | |
| ToppCell | Myeloid-Myeloid-D_(Mast_cell)|Myeloid / shred on cell class and cell subclass (v4) | 3.81e-04 | 171 | 37 | 3 | 5f1aafc4c55a9c6c3153430186a8a351425a3cb9 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD8-Tem/emra_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.81e-04 | 171 | 37 | 3 | f28684ea0e74a22f4c140658496068e28a6d3605 | |
| ToppCell | ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, Lineage and Cell Type | 3.81e-04 | 171 | 37 | 3 | 72c448a0dc4c569bd6b465f9aa395f38034e7ea6 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-pDCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.81e-04 | 171 | 37 | 3 | 1f8e66073088fc1969782e443bf00f8c1877ea91 | |
| ToppCell | COVID-pDC|COVID / Condition, Cell_class and T cell subcluster | 3.88e-04 | 172 | 37 | 3 | 3ecbb000495dde32f6153ef6bdea9c8802ff3985 | |
| ToppCell | COVID-pDC-|COVID / Condition, Cell_class and T cell subcluster | 3.88e-04 | 172 | 37 | 3 | a7827faa1afab51fdaf0cb1a2babcd2e00d411e5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.94e-04 | 173 | 37 | 3 | ee972d9cc68755926512fd3bbe1267098c67cd94 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Basophil|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.94e-04 | 173 | 37 | 3 | 8ca650542655c27516029e5bace97ff1b9dcc256 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-04 | 173 | 37 | 3 | 3612772632ddf11eb48579cae9a8ccab6b3f1f52 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.94e-04 | 173 | 37 | 3 | 4282b47b33325472f52a4085986988911a372ed8 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-04 | 173 | 37 | 3 | 4dc261ebcdb9bdcfca1451da1bd254f0dc5de203 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.01e-04 | 174 | 37 | 3 | 778e0317c0c63fa4efd74114feb760975b819d92 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.01e-04 | 174 | 37 | 3 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 4.08e-04 | 175 | 37 | 3 | 2eca4c168dea2017ea0e383006e28abed22f32ec | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.08e-04 | 175 | 37 | 3 | 97fe431f224b592b3076632d101e19136c138dcc | |
| ToppCell | facs-Skin-nan-18m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-04 | 176 | 37 | 3 | 086197acbfec4ac0c15b7e9721871aaa9e32e219 | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.22e-04 | 177 | 37 | 3 | 5cdf413f82376a95467322b16d10b0d1e7557e2d | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.22e-04 | 177 | 37 | 3 | fdf2af00fc971f0cd3915e1416e4a256458d6ea8 | |
| ToppCell | metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 4.22e-04 | 177 | 37 | 3 | 43e1d0d3cf8f0c02e67d91f8dd1761df23d59e07 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.22e-04 | 177 | 37 | 3 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.22e-04 | 177 | 37 | 3 | 12f8627124acbf436e75681ff1ce429ff5e3f256 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.22e-04 | 177 | 37 | 3 | 3645e2f4a48283f290f85c49c3e79e3f58ac9aa6 | |
| ToppCell | Control-T/NK-NK|Control / Disease group,lineage and cell class (2021.01.30) | 4.29e-04 | 178 | 37 | 3 | 079fd19bdeed86bf985c4083af432432d66ad546 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.36e-04 | 179 | 37 | 3 | b35a7f8115c997c390201da01d7cb10b10769aec | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.36e-04 | 179 | 37 | 3 | 6405010e8136a4d9bab356f628e36e3194911112 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Macrophage|lymph-node_spleen / Manually curated celltypes from each tissue | 4.36e-04 | 179 | 37 | 3 | b4430f633711cecf793e8e76e766a66ff1eff473 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 4.43e-04 | 180 | 37 | 3 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | moderate-Myeloid-pDC|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.43e-04 | 180 | 37 | 3 | a0751ad5e42a21cb107d900abfa9ee967a0069fc | |
| ToppCell | NS-moderate-d_16-33-Myeloid-pDC|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.43e-04 | 180 | 37 | 3 | 144818e69613296cde43f29cb8c20899c670b319 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.43e-04 | 180 | 37 | 3 | be9d99a2e22e63824fb2a91974379da45160ae43 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.50e-04 | 181 | 37 | 3 | a8e9ea73c24109a5d4d28bc0577cc869ad932a4d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.57e-04 | 182 | 37 | 3 | d524ad5cf00f05ee27c9db2ffa2d4e30a1e2e21a | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-pDC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.57e-04 | 182 | 37 | 3 | 02c0824373a0ecebc922d4ca848ace9d570722c4 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.57e-04 | 182 | 37 | 3 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.57e-04 | 182 | 37 | 3 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.65e-04 | 183 | 37 | 3 | f8b636391f752e379a5c5575fd898bdf0907a3b8 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.65e-04 | 183 | 37 | 3 | 5472cdce6d99314d229418412acf1fff6340db7d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.65e-04 | 183 | 37 | 3 | 93213124e55d1b673dd345188caf8b5bd31d99fe | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.72e-04 | 184 | 37 | 3 | f6d6b3ddada66dae28d3306415bf4efe0934208a | |
| ToppCell | facs-SCAT-Fat-3m-Lymphocytic-T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-04 | 184 | 37 | 3 | cdacb61878e0824b8416bf365d89965797208359 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.72e-04 | 184 | 37 | 3 | 5939527d24d299e562e707469c9123890edd76be | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.72e-04 | 184 | 37 | 3 | ae0a77e3e520a246b17776bb19503519636b02ee | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.72e-04 | 184 | 37 | 3 | a2191dd5546efd357b23e625beb3c5820476f243 | |
| ToppCell | Endothelial-E|World / shred on cell class and cell subclass (v4) | 4.72e-04 | 184 | 37 | 3 | b4c561924c508536fd2112e91e32176b95fdf63a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.79e-04 | 185 | 37 | 3 | b5277190866d9eb5b85eceaa5ba116ea6e6f286b | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-04 | 185 | 37 | 3 | de353368f4f6a7a0a66e391d586879876fbe2734 | |
| ToppCell | normal-na-Myeloid-plasmacytoid_dendritic_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.79e-04 | 185 | 37 | 3 | 3091870a5bf8ecb963e560b47c8502bae367416c | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.79e-04 | 185 | 37 | 3 | 1d731d69d8db8aef4a11439b8abd1030c7e6ac4c | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.79e-04 | 185 | 37 | 3 | b8d02c9426740ffcb69d2e6f95473b388149d297 | |
| ToppCell | ICU-NoSEP-Myeloid-pDC|ICU-NoSEP / Disease, Lineage and Cell Type | 4.79e-04 | 185 | 37 | 3 | 7564a47df4a4e3af30d40aa0f48bd9d9c82358ae | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-plasmacytoid_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.87e-04 | 186 | 37 | 3 | a07694caf7fede06a47636725bcc7f09909cdf07 | |
| ToppCell | Multiple_Sclerosis-Myeloid-pDC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 4.87e-04 | 186 | 37 | 3 | 330a4f669adea91ff9f2dff2de2210f5e3401e19 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.87e-04 | 186 | 37 | 3 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.87e-04 | 186 | 37 | 3 | d57c40b3fe5cfc87e771df76533d9a3e94678b04 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.87e-04 | 186 | 37 | 3 | 90eaf6ffb4ce0c34fa1e79f0c8f36f217f44973b | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.87e-04 | 186 | 37 | 3 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.87e-04 | 186 | 37 | 3 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.87e-04 | 186 | 37 | 3 | bd8a9753df219084e19e7f94447856e86608325c | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.95e-04 | 187 | 37 | 3 | f0de86ef25e344d9b1860ee26308877d6c25ed31 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-04 | 187 | 37 | 3 | a12f383b02b07af32cc53a154685df8dba8fbd3f | |
| ToppCell | IIH-pDC-|IIH / Condition, Cell_class and T cell subcluster | 4.95e-04 | 187 | 37 | 3 | ad87b146ea8dd9f695e722f8f0e8e1057c7f3167 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-04 | 187 | 37 | 3 | c40c152fa14e6afc9188549534b64ccbaded56b3 | |
| ToppCell | (2)_5-FU-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|(2)_5-FU / Stress and Cell class | 4.95e-04 | 187 | 37 | 3 | 6bbf0f7fe203274dae8d582652f35cd3187c0065 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.95e-04 | 187 | 37 | 3 | ec4b694487cc446999c7b27b119950a4f252c4b3 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.95e-04 | 187 | 37 | 3 | 6cf7be5401b81a4eeb30840fb3733d61a24af539 | |
| Disease | Eye Diseases, Hereditary | 1.93e-05 | 6 | 34 | 2 | C0015398 | |
| Disease | lithostathine-1-alpha measurement | 2.70e-05 | 7 | 34 | 2 | EFO_0801083 | |
| Disease | obsolete_interleukin-1 alpha measurement | 2.70e-05 | 7 | 34 | 2 | EFO_0802653 | |
| Disease | Bone Diseases | 5.77e-05 | 10 | 34 | 2 | C0005940 | |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 1.09e-04 | 216 | 34 | 4 | EFO_0007925, EFO_0007927 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 1 measurement | 1.34e-04 | 15 | 34 | 2 | EFO_0008208 | |
| Disease | Nystagmus | 2.67e-04 | 21 | 34 | 2 | HP_0000639 | |
| Disease | complement factor H-related protein 2 measurement | 5.13e-04 | 29 | 34 | 2 | EFO_0600055 | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian carcinoma | 9.30e-04 | 39 | 34 | 2 | EFO_0001075, EFO_0004920, GO_0097328, MONDO_0009354 | |
| Disease | colon cancer (biomarker_via_orthology) | 9.30e-04 | 39 | 34 | 2 | DOID:219 (biomarker_via_orthology) | |
| Disease | glycerophospholipid measurement | 1.46e-03 | 49 | 34 | 2 | EFO_0007630 | |
| Disease | urate measurement, spine bone mineral density | 2.05e-03 | 58 | 34 | 2 | EFO_0004531, EFO_0007701 | |
| Disease | osteoarthritis | 2.12e-03 | 222 | 34 | 3 | MONDO_0005178 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VYFCYDGSPYRSYED | 256 | Q9H2F3 | |
| SRTKYYYLGGYCFPA | 961 | O94910 | |
| GDSSNYYYISPFCRY | 411 | Q96QF0 | |
| GMACRSGKYYFYDNY | 116 | Q5TFE4 | |
| ALYAQDPSTGCYMYY | 301 | Q9NQR1 | |
| GNYCKYYGYRNPSCE | 416 | Q7L2J0 | |
| PSMTEDYAGRYRCYY | 86 | Q8NHJ6 | |
| DYAGRYRCYYRSPVG | 91 | Q8NHJ6 | |
| DGTTPYCCSYYAYIG | 41 | Q96J86 | |
| YYTHYKCDSPGMCGY | 206 | Q5FYB0 | |
| PGYECYCKQGTYYDP | 1446 | Q14766 | |
| GNCTKYYKGTGYYTC | 241 | P48167 | |
| PSTVYDSAGRYRCYY | 86 | O75023 | |
| YSYRCDYYNDCGDGS | 2756 | P98164 | |
| PYKRGFYCGDDSIRY | 31 | O43688 | |
| GTYRCYGSFNDSPYK | 291 | Q9H7L2 | |
| PEDEAEYYCLLYYGG | 101 | P04211 | |
| VGNYTCYADGYEQVY | 316 | Q8N475 | |
| QYTYGYEYLGACPRL | 1431 | Q9C0G6 | |
| PDCYYSIGRENYNQY | 136 | P14384 | |
| EECRGYYYVYKDGDP | 966 | Q13698 | |
| PGEEYTCGTNFAYYY | 1346 | Q13698 | |
| GYECYCKQGFYYDGN | 1016 | Q9NS15 | |
| LGYGYDCKYSYTSGF | 11 | Q3LI60 | |
| NYYGSLDYGCSYGSE | 6 | Q3LI68 | |
| DDVGYYSCSLYTYPQ | 101 | Q15762 | |
| VNYKGYFKCECYPGY | 391 | Q14114 | |
| CPEGTNAYRSYCYYF | 36 | P05451 | |
| CPEGTNAYRSYCYYF | 36 | P48304 | |
| YQIRVTCDDYYYGFG | 181 | P78504 | |
| YCGKPYTYAYGLGLN | 426 | Q16518 | |
| YYVCYKCRKAYFGGE | 4541 | O75592 | |
| LQGYRYYDPKTCGFD | 176 | P00505 | |
| SEYPEKYYPDYCSGE | 231 | A8MXE2 | |
| SDYAKYYALVCYGPG | 456 | Q12884 | |
| YYGEYYNAPLKRGSD | 676 | Q6UWL2 | |
| PYECKECGKGFYYSY | 216 | P51504 | |
| YECFGGEYRPKVYDQ | 2006 | Q9UPU5 | |
| TPYEGNYYKCSDYGR | 321 | Q5JVG2 |